Galena buys Abstral in $15M Orexo deal; Novo Nordisk drug helps diabetes patients lose weight;

 @FierceBiotech: New special report: Biopharma's Top R&D Spenders - 2012. Report | Follow @FierceBiotech

@JohnCFierce: Updated AstraZeneca story. They buried the news on job cuts, thousands of relocations. Major upheaval. Story | Follow @JohnCFierce

@RyanMFierce: CRO buys chunk of mobile outfit behind virtual Pfizer trial. Article | Follow @RyanMFierce

> Orexo AB has sold Abstral (fentanyl) to Galena Biopharma ($GALE) for $10 million upfront and an additional $5 million within the first 12 months after signing, plus low double-digit royalties and milestone payments based on pre-specified sales levels. Release

> Israel-based Proteologics and GlaxoSmithKline ($GSK) have extended a research collaboration, originally for three years, for an additional year. Release

> Novo Nordisk's ($NVO) drug Victoza was successful at helping obese patients with Type 2 diabetes lose weight in a late-stage clinical trial. News

Pharma News

@FiercePharma: German pricing watchdog didn't like Bayer's data on Eylea. No add'l benefit, IQWiG says. Bayer will respond. Report | Follow @FiercePharma

@EricPFierce: Greece urged to take new twist on compulsory licenses to get hands on cheaper drugs. Story | Follow @EricPFierce

> Abbott CEO scores $25M, while new AbbVie chief nets $8M. More

> AstraZeneca to cut 1,600 jobs in global reshuffle. Story

> Apotex, Waxman take sides against pharma in Supreme Court generics cases. Article

Medical Device News

 @FierceMedDev: Med tech incubator InCube Labs raises $30M in Texas expansion. More | Follow @FierceMedDev

 @MarkHFierce: The cosmetic laser industry is consolidating, in a deal that is pretty big (for the device industry. Release | Follow @MarkHFierce

 @DamianFierce: India wants to launch two independent committees to make sure clinical trials are ethical. Story | Follow @DamianFierce

> Will Panasonic sell its healthcare division for $1.05B? News

> FDA intensifies warning on Stryker's Neptune devices. More

> Molecular biosensor diagnoses cancer by spotting high lactate levels. Story

CRO News

> Sunshine Biopharma on the hunt for CMO partner. Item

> India deepens effort to regulate clinical trials. Article

> Ex-Aptuit researcher convicted of cooking Roche, AZ data. More

> BioClinica, CoreLab merge after buyouts. Report

> After CRO sell-off, Radiant doubles down on trial sites. Story

Biotech IT News

> CRO buys chunk of mobile outfit behind virtual Pfizer trial. Story

> BioClinica CEO: No cuts planned after CoreLab merger, private equity sale. Report

> Spiral Genetics scores $3M VC round from major backer. Item

> Novartis eyes cancer patients with two mobile apps for iPhone, Android. Article

> Genomic analysis startup scores VA contract for major study. More

And Finally... The Mayo Clinic in Minnesota is the third U.S. leading clinical site to agree to hold a clinical trial for a Lou Gehrig's stem cell therapy developed by Israel-based BrainStorm. Story

Suggested Articles

With a new research team, outlook and more than a little help from the tech world, GSK has been quietly going about shoring up its pipeline.

The World Health Organization has called out Big Pharma for its dearth of antibiotic innovation amid a growing threat of antimicrobial resistance.

The trial hit its primary endpoint by the time of an interim analysis, enabling Chi-Med to stop the study and start work on a filing for approval.